Common Contracts
6 similar null contracts by Xenon Pharmaceuticals Inc.
Re: Employment AgreementXenon Pharmaceuticals Inc. • January 14th, 2021 • Pharmaceutical preparations • British Columbia
Further to your discussion with the Board to transition from the Chief Executive Officer role, we are pleased to offer you the position of Executive Chair of the Board of Directors, from the Company’s 2021 annual meeting of shareholders expected to take place on or about June 4, 2021 (the “Effective Date”) to the Company’s 2022 annual meeting of shareholders expected to take place in June 2022 (the “End Date”) (from the Effective Date to the End Date, the “Term”), on the terms and conditions set forth in this Employment Agreement. Unless previously terminated in accordance with Section M, N, O or P or extended by mutual written agreement, your employment with the Company will automatically end as of the End Date. Please note that this new Employment Agreement will replace and supersede any earlier Employment Agreements you may have had with the Company as of the Effective Date.
Re: Employment AgreementXenon Pharmaceuticals Inc. • January 14th, 2021 • Pharmaceutical preparations • British Columbia
We are pleased to offer you a promotion to the position of Chief Financial Officer (“CFO”) with Xenon Pharmaceuticals Inc. (the “Company”), effective as of the Company’s 2021 annual meeting of shareholders expected to take place on or about June 4, 2021(the “Effective Date”), on the terms and conditions set forth in this Employment Agreement. Please note that this new Employment Agreement will replace and supersede your earlier Employment Agreement as of the Effective Date. You will be credited for all purposes with your service to the Company back to your start date of June 22, 2015, unless stated otherwise.
Re: Employment AgreementXenon Pharmaceuticals Inc. • January 14th, 2021 • Pharmaceutical preparations • British Columbia
We are pleased to offer you a promotion to the position President & Chief Executive Officer (“CEO”) with Xenon Pharmaceuticals Inc. (the “Company”), effective as of the Company’s 2021 annual meeting of shareholders expected to take place on or about June 4, 2021 (the “Effective Date”), on the terms and conditions set forth in this Employment Agreement. Please note that this new Employment Agreement will replace and supersede your earlier Employment Agreement as of the Effective Date. You will be credited for all purposes with your service to the Company back to your start date of October 21, 2013, unless stated otherwise.
Re: Amended and Restated Employment AgreementXenon Pharmaceuticals Inc. • March 25th, 2019 • Pharmaceutical preparations
We are pleased to offer you this Amended and Restated Employment Agreement which replaces and supersedes your earlier Employment Agreement. You will be credited for all purposes with your service to the Company back to your start date of October 21, 2013. As of March 19, 2019 (the “Effective Date”), you will continue to be engaged by the Company in the full-time position of President & CFO.
Re: Amended and Restated Employment Agreement (CDN Executive)Xenon Pharmaceuticals Inc. • March 25th, 2019 • Pharmaceutical preparations
We are pleased to offer you this Amended and Restated Employment Agreement which replaces and supersedes your earlier Employment Agreement. You will be credited for all purposes with your service to the Company back to your start date of [DATE]. As of [DATE] (the “Effective Date”), you will continue to be engaged by the Company in the full-time position of [TITLE].
Re: Amended and Restated Employment AgreementXenon Pharmaceuticals Inc. • March 25th, 2019 • Pharmaceutical preparations
We are pleased to offer you this Amended and Restated Employment Agreement which replaces and supersedes your earlier Employment Agreement. You will be credited for all purposes with your service to the Company back to your start date of July 1, 2000. As of March 19, 2019 (the “Effective Date”), you will continue to be engaged by the Company in the full-time position of CEO.
